BioNTech
BNTX
BNTX
194 hedge funds and large institutions have $1.77B invested in BioNTech in 2020 Q4 according to their latest regulatory filings, with 82 funds opening new positions, 43 increasing their positions, 46 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
6% less call options, than puts
Call options by funds: $181M | Put options by funds: $193M
7% less repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 46
1.06% less ownership
Funds ownership: 10.2% → 9.13% (-1.1%)
Holders
194
Holding in Top 10
1
Calls
$181M
Puts
$193M
Top Buyers
| 1 | +$64.6M | |
| 2 | +$49.3M | |
| 3 | +$37M | |
| 4 |
Morgan Stanley
New York
|
+$20.6M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$18.2M |
Top Sellers
| 1 | -$157M | |
| 2 | -$78.8M | |
| 3 | -$71.8M | |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$64.3M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$56.4M |